Cited by 7Glioma Diagnosis and TreatmentCancer-related molecular mechanisms researchRNA Research and Splicing

Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma

Open access
Kameda-Smith, Michelle M., Zhu, Helen, Luo, En-Ching, Suk, Yujin, Xella, Agata, Yee, Brian, Chokshi, Chirayu, Xing, Sansi +23 more·2022·Nature Communications

Published version of a preprint

Abstract

Pediatric medulloblastoma (MB) is the most common solid malignant brain neoplasm, with Group 3 (G3) MB representing the most aggressive subgroup. MYC amplification is an independent poor prognostic factor in G3 MB, however, therapeutic targeting of the MYC pathway remains limited and alternative therapies for G3 MB are urgently needed. Here we show that the RNA-binding protein, Musashi-1 (MSI1) is an essential mediator of G3 MB in both MYC -overexpressing mouse models and patient-derived xenografts. MSI1 inhibition abrogates tumor initiation and significantly prolongs survival in both models. We identify binding targets of MSI1 in normal neural and G3 MB stem cells and then cross referenced these data with unbiased large-scale screens at the transcriptomic, translatomic and proteomic levels to systematically dissect its functional role. Comparative integrative multi-omic analyses of these large datasets reveal cancer-selective MSI1-bound targets sharing multiple MYC associated pathways, providing a valuable resource for context-specific therapeutic targeting of G3 MB.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-022-35118-3

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Authors
Kameda-Smith, M. M., Zhu, H., Luo, E.-C., Suk, Y., Xella, A., Yee, B., Chokshi, C., Xing, S., Tan, F., Fox, R. G., Adile, A. A., Bakhshinyan, D., Brown, K., Gwynne, W. D., Subapanditha, M., Miletic, P., Picard, D., Burns, I., Moffat, J., Paruch, K., Fleming, A., Hope, K., Provias, J. P., Remke, M., Lu, Y., Reya, T., Venugopal, C., Reimand, J., Wechsler-Reya, R. J., Yeo, G. W., & Singh, S. K.
Affiliations
  • McMaster University (CA)
  • Ontario Institute for Cancer Research (CA)
  • University of California San Diego (US)
  • Sanford Burnham Prebys Medical Discovery Institute (US)
  • University of Toronto (CA)
  • Düsseldorf University Hospital (DE)
  • Masaryk University (CZ)
  • Columbia University Irving Medical Center (US)
Corresponding author
  • Yeo, Gene W.
  • Singh, Sheila K.
Venue
Nature Communications
Published
2022-12-06
Volume
13
Issue
1
Pages
7506-7506
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4311583012
Cited by
7
References
8
Citations by year
2025: 2 · 2024: 1 · 2023: 4
FWCI
1.09
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • California Institute for Regenerative Medicine
  • Alex's Lemonade Stand Foundation for Childhood Cancer (CA159859)
  • Neurosurgery Research and Education Foundation
  • McMaster University
  • Ontario Institute for Cancer Research
  • Government of Ontario
  • University of California, San Diego
  • Canadian Institutes of Health Research
  • Natural Sciences and Engineering Research Council of Canada
  • National Heart, Lung, and Blood Institute (T32HL086344)
  • National Cancer Institute (CA009523, CA30199, CA159859, T32CA009523, P30CA030199, R01CA159859, R35CA197699, P30CA30199)
Topics
  • Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Keywords
pediatric medulloblastoma, Group 3 medulloblastoma, MYC amplification, Musashi-1, RNA-binding proteins, protein-protein interaction network, post-transcriptional regulation, cancer stem cells, patient-derived xenografts, multi-omics integration, therapeutic target
MeSH terms
Animals, Brain Neoplasms, Cerebellar Neoplasms, Humans, Medulloblastoma, Nerve Tissue Proteins, RNA-Binding Proteins, Proteomics, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review